Article
Tangles, not TANGO: targeting tau aggregates - Nature Aging
Rating:
0.0
Views:
34
Likes:
1
Library:
1
Targeting tau in addition to amyloid-β could be the next phase of disease modification in Alzheimer's disease. The TANGO trial of gosuranemab, which binds the tau N terminus, affected neither clinical outcomes nor brain levels of aggregated tau. The results highlight the importance and challenge of reducing aggregated tau.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value